Why did you pursue an NIH SBIR Phase I grant?

22 Oct 2026 · 3 min
2:50

In this interview, the founder explains why their academic‑origin startup chose to apply for an NIH SBIR Phase I award. They note that, from the start, they recognized SBIR as an alternative to venture capital for early‑stage funding. The timing of the application was delayed by uncertainty around the SBIR re‑authorization cycle, which took about six months. Initially the team pursued VC and angel investors, but after the SBIR program was re‑authorized they shifted focus. Participation in the regional i‑Corps program at UMass Boston provided customer interviews that validated the problem they were tackling. Consequently, they decided to frame their SBIR proposal around a central scientific hypothesis and technical challenge rather than a conventional product pitch, emphasizing measurable experiments and benchmarks. The founder hints that the grant money will be used to advance the core scientific thesis, develop the technology, and hire/retain AI talent, aligning the funding with a research‑focused growth strategy.

More from Stacy

0:49
youtube.com

SBIR grant vs contract

today
0:50
youtube.com

Why SBIR reviewers don’t give a 💩about the MDs & PhDs on your team…

5d ago
0:48
youtube.com

5 PhDs & MDs. ZERO FUNDING? Too smart for SBIR grants?

6d ago
1:37
youtube.com

It took a LONG time to write an SBIR proposal. Here's why...

1w ago
0:51
youtube.com

I hope I’m not the only one who experienced this…

1w ago
4:32
youtube.com

Applying for NIH SBIR in Jan 5, 2027? You Should Be Starting NOW. Here's why...

1w ago
0:45
youtube.com

More SBIR grants? More problems?

1w ago
0:07
youtube.com

If you are a grant writer, you know this feeling

1w ago
16:36
youtube.com

How to Get Invited to Apply for $305K in NSF SBIR Funding || Step-by-Step Guide

1w ago
0:39
youtube.com

I just finished an NIH SBIR grant. That was HARD

1w ago
0:43
youtube.com

It’s time to start 2027 SBIR grants! Here’s why…

2w ago
See all content